Dossier
hair loss drugs
Coverage of hair loss drugs in the Nexus archive.
- The mysterious case of Eli Lilly’s obesity drug
Eli Lilly's obesity drug retatrutide is being made available to one individual through the FDA's 'compassionate use' program. The article discusses this development alongside broader questions about drugmaker acquisitions and the investment potential of hair loss drugs, as covered in a podcast episode.